Similar articles

• Recombinant factor VIIa and factor VIII treatment for acquired factor VIII deficiency: a case of repeated thrombotic endotracheal occlusion in a mechanically ventilated patient.

  Lauer S, Westphal M, Fischer LG, Meissner A, Van Aken H, Freise H. Lauer S, et al. Crit Care. 2011;15(2):407. doi: 10.1186/cc10041. Epub 2011 Mar 9. Crit Care. 2011. PMID: 21418550 Free PMC article. No abstract available.
• Successful management of massive intraperitoneal bleeding in a hemophilia A patient with inhibitor by surgical debridement of the incomplete hematoma and administration of recombinant factor VIII and activated factor VII.

  Koyama T, Nagao T, Tsunozaki H, Arai M, Miura O. Koyama T, et al. Pathophysiol Haemost Thromb. 2006;35(5):405-7. doi: 10.1159/000097697. Pathophysiol Haemost Thromb. 2006. PMID: 17230044 No abstract available.
• Management of coronary artery disease in a severe haemophilia patient with high titre inhibitor and anaphylaxis.

  Rivolta GF, Di Perna C, Franchini M, Ippolito L, Maurizio AR, Rocci A, Tagliaferri A. Rivolta GF, et al. Haemophilia. 2009 Sep;15(5):1161-3. doi: 10.1111/j.1365-2516.2009.02050.x. Epub 2009 May 26. Haemophilia. 2009. PMID: 19486169 No abstract available.
• Relationship between factor VIII replacement therapy and joint damage in severe haemophilia.

  Lowe GD. Lowe GD. Blood Coagul Fibrinolysis. 1997 Aug;8 Suppl 1:S3-5. Blood Coagul Fibrinolysis. 1997. PMID: 9351528 Review.
• Dose titration of recombinant factor VIIa using thromboelastograph monitoring in a child with hemophilia and high titer inhibitors to factor VIII: a case report and brief review.

  Trowbridge CC, Stammers AH, Ciccarelli N, Klayman M. Trowbridge CC, et al. J Extra Corpor Technol. 2006 Sep;38(3):254-9. J Extra Corpor Technol. 2006. PMID: 17089513 Free PMC article. Review.